{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:58:08Z","timestamp":1761991088924,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"ational Science and Technology Major Project,","award":["2018ZX09721002001]"],"award-info":[{"award-number":["2018ZX09721002001]"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jgar.2020.08.019","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T07:38:23Z","timestamp":1599032303000},"page":"113-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pharmacokinetic and pharmacodynamic profiling of generic amphotericin B colloidal dispersion in a rat model of invasive candidiasis"],"prefix":"10.1016","volume":"23","author":[{"given":"Huanhuan","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuancheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cancan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2020.08.019_bib0005","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/jac\/dkt083","article-title":"China-SCAN Team. Invasive candidiasis in intensive care units in China: a multicentre prospective observational study","volume":"68","author":"Guo","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.08.019_bib0010","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2020.08.019_bib0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/CCM.0b013e318206c1ca","article-title":"Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study","volume":"39","author":"Kett","year":"2011","journal-title":"Crit Care Med"},{"issue":"Suppl 2","key":"10.1016\/j.jgar.2020.08.019_bib0020","first-page":"s93","article-title":"Liposomal and lipid-based formulations of amphotericin B","volume":"10","author":"De Marie","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.jgar.2020.08.019_bib0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2710.1993.tb00605.x","article-title":"Amphotericin B and its delivery by liposomal and lipid formulations","volume":"18","author":"Gates","year":"1993","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jgar.2020.08.019_bib0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1399-3062.1999.010406.x","article-title":"Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability","volume":"1","author":"Tiphine","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jgar.2020.08.019_bib0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-5173(91)90249-N","article-title":"Novel antifungal drug delivery: stable amphotericin B-cholesteryl sulfate discs","volume":"75","author":"Guo","year":"1991","journal-title":"Int J Pharm"},{"year":"2017","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","author":"Clinical and Laboratory Standards Institute (CLSI)","key":"10.1016\/j.jgar.2020.08.019_bib0040"},{"year":"2004","series-title":"Clinical use and interpretation of serologic tests for Toxoplasma gondii; approved guideline","author":"Clinical and Laboratory Standards Institute (CLSI)","key":"10.1016\/j.jgar.2020.08.019_bib0045"},{"key":"10.1016\/j.jgar.2020.08.019_bib0050","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","volume":"48","author":"Pfaller","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2020.08.019_bib0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jhin.2016.08.004","article-title":"Multidrug-resistant Candida auris:\u2019 new kid on the block\u2019 in hospital-associated infections?","volume":"94","author":"Chowdhary","year":"2016","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jgar.2020.08.019_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2014.12.033","article-title":"Surveillance of antifungal susceptibilities in clinical isolates of Candida species at 36 hospitals in China from 2009 to 2013","volume":"33","author":"Zhang","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2020.08.019_bib0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/1469-0691.12513","article-title":"Update on antifungal resistance in Aspergillus and Candida","volume":"20","author":"Arendrup","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2020.08.019_bib0070","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1517\/14656566.4.8.1277","article-title":"The lipid formulations of amphotericin B","volume":"4","author":"Herbrecht","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jgar.2020.08.019_bib0075","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4065\/mcp.2011.0247","article-title":"Current concepts in antifungal pharmacology","volume":"86","author":"Lewis","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jgar.2020.08.019_bib0080","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1128\/AAC.45.3.922-926.2001","article-title":"Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model","volume":"45","author":"Andes","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.08.019_bib0085","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/AAC.50.3.935-942.2006","article-title":"Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases","volume":"50","author":"Hong","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.08.019_bib0090","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1128\/AAC.50.2.674-684.2006","article-title":"Pharmacokinetic\u2013pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models","volume":"50","author":"Andes","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.08.019_bib0095","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1086\/315643","article-title":"Candida albicansComparative efficacy and distribution of lipid formulations of amphotericin B in experimental infection of the central nervous system","volume":"182","author":"Groll","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2020.08.019_bib0100","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019653","article-title":"Antifungal pharmacokinetics and pharmacodynamics","volume":"5","author":"Lepak","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jgar.2020.08.019_bib0105","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1016\/j.bmc.2016.11.008","article-title":"Animal models in the pharmacokinetic\/pharmacodynamic evaluation of antimicrobial agents","volume":"24","author":"Zhao","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jgar.2020.08.019_bib0110","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1128\/AAC.35.6.1029","article-title":"Single-dose pharmacokinetics and tolerance of a cholesteryl sulfate complex of amphotericin B administered to healthy volunteers","volume":"35","author":"Sanders","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.08.019_bib0115","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1023\/A:1011923704731","article-title":"Elucidation of human amphotericin B pharmacokinetics: identification of a new potential factor affecting interspecies pharmacokinetic scaling","volume":"15","author":"Robbie","year":"1998","journal-title":"Pharm Res"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520302253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520302253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:55:34Z","timestamp":1761990934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716520302253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":23,"alternative-id":["S2213716520302253"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2020.08.019","relation":{},"ISSN":["2213-7165"],"issn-type":[{"type":"print","value":"2213-7165"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic and pharmacodynamic profiling of generic amphotericin B colloidal dispersion in a rat model of invasive candidiasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2020.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}